Alafair Biosciences Secures Agreement with Premier, Inc. for VersaWrap® Hydrogel Sheet

Wednesday, July 03, 2024

Alafair Biosciences, Inc., has announced that its leading product, VersaWrap Hydrogel Sheet, has secured a national group purchasing agreement with Premier, Inc., effective from July 1, 2024.

This agreement allows Premier members to benefit from specially negotiated pricing and terms for VersaWrap, a class II medical device designed to facilitate tissue gliding and reduce reoperations, thereby improving patient outcomes.

Appreciation for the agreement, stating, "They are honored that Premier has recognized the value of our technology.

This partnership presents a significant opportunity for Alafair to expand the reach of VersaWrap to Premier members and healthcare providers nationwide.

We anticipate that this collaboration will further drive our growth and enable us to continue delivering exceptional results for patients."

Premier is a leading healthcare improvement company that brings together a network of approximately 4,350 U.S. hospitals and 300,000 providers.

Through integrated data, analytics, supply chain solutions, and consulting services, Premier aims to enhance care quality, outcomes, and cost-efficiency across the healthcare industry.


Harvard Medical School - Leadership in Medicine Southeast Asia47th IHF World Hospital CongressHealthcare CNO Summit - USAHealthcare CMO Summit - USAHealthcare CFO, Financial Strategy & Revenue Cycle SummitHealthcare CEO & Executive Strategy Summit